Hydration Pharmaceuticals Company LimitedASX: HPC

Prospectus - Non Renounceable Rights Issue

· Issued by Hydration Pharmaceuticals Company Limited via ASX

Filed with ASX ·

The Hydration Pharmaceuticals Company Limited ACN 620 385 677 PROSPECTUS Non-renounceable pro-rata entitlement offer of 2 New Shares for every 3 Shares held on the Record Date at an issue price of $0.004 per New Share, together with 1 free-attaching New Option for every 2 New Shares subscribed for...

View Attachment

6ix is reading this filing.

Hydration Pharmaceuticals Company Limited on 6ix

Earlier from Hydration Pharmaceuticals

All Hydration Pharmaceuticals news releases